Altre lingue Rakovina Therapeutics Inc.

Azioni

RKV

CA75103L1013

Tempo differito Toronto S.E. Altri mercati azionari 15:38:23 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,09 ^CAD	0,00%		0,00%	+5,88%

09/04	Rakovina Therapeutics presenta al Meeting annuale dell'Associazione Americana per la Ricerca sul Cancro	MT
2023	Rakovina Therapeutics annuncia la nomina di un membro del Comitato consultivo scientifico	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting	09/04
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today	09/04
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration	02/04
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024	01/04
Rakovina Therapeutics Announces Strategic Pivot to AI	27/03
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update	28/11
Rakovina Therapeutics Announces Appointment to Scientific Advisory Board	27/11
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27/11
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27/11
Rakovina Therapeutics Appoints Prof. Artem Cherkasov to the Scientific Advisory Board	27/11
Rakovina Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/11
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member	20/11
Rakovina Therapeutics Inc. Announces Appointment of Prof. Petra Hamerlik as New Scientific Advisory Board Member	20/11
Rakovina Therapeutics continues to make progress as company provides corporate update	13/09/23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29/08/23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29/08/23
Rakovina Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting	29/06/23
Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update	31/05/23
Rakovina Therapeutics Inc. Announces Closing of $1.5 Million Convertible Debenture Financing	30/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Rakovina Therapeutics Inc.

Azioni

RKV

CA75103L1013

Altre lingue

Filtri